0001193125-19-019639 Sample Contracts

Harpoon Therapeutics, Inc. [·] Shares Common Stock ($0.0001 par value per share) Underwriting Agreement

Harpoon Therapeutics, Inc. • January 29th, 2019 • Biological products, (no disgnostic substances) • New York

• Company
  Harpoon Therapeutics, Inc.
• Filed
  January 29th, 2019
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

ASSET TRANSFER AGREEMENT BETWEEN MAVERICK THERAPEUTICS, INC. AND HARPOON THERAPEUTICS, INC. Dated as of December 30, 2016 CONFIDENTIAL

Asset Transfer Agreement • January 29th, 2019 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Asset Transfer Agreement
• Filed
  January 29th, 2019
• Company
  Harpoon Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

* = This schedule or exhibit has been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of the omitted schedule and/or exhibit will be furnished to the Securities and Exchange Commission on request.

Contract

Harpoon Therapeutics, Inc. • January 29th, 2019 • Biological products, (no disgnostic substances) • New York

• Company
  Harpoon Therapeutics, Inc.
• Filed
  January 29th, 2019
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

[ ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.